Literature DB >> 34115750

A soft voting ensemble classifier for early prediction and diagnosis of occurrences of major adverse cardiovascular events for STEMI and NSTEMI during 2-year follow-up in patients with acute coronary syndrome.

Syed Waseem Abbas Sherazi1, Jang-Whan Bae2, Jong Yun Lee1.   

Abstract

OBJECTIVE: Some researchers have studied about early prediction and diagnosis of major adverse cardiovascular events (MACE), but their accuracies were not high. Therefore, this paper proposes a soft voting ensemble classifier (SVE) using machine learning (ML) algorithms.
METHODS: We used the Korea Acute Myocardial Infarction Registry dataset and selected 11,189 subjects among 13,104 with the 2-year follow-up. It was subdivided into two groups (ST-segment elevation myocardial infarction (STEMI), non ST-segment elevation myocardial infarction NSTEMI), and then subdivided into training (70%) and test dataset (30%). Third, we selected the ranges of hyper-parameters to find the best prediction model from random forest (RF), extra tree (ET), gradient boosting machine (GBM), and SVE. We generated each ML-based model with the best hyper-parameters, evaluated by 5-fold stratified cross-validation, and then verified by test dataset. Lastly, we compared the performance in the area under the ROC curve (AUC), accuracy, precision, recall, and F-score.
RESULTS: The accuracies for RF, ET, GBM, and SVE were (88.85%, 88.94%, 87.84%, 90.93%) for complete dataset, (84.81%, 85.00%, 83.70%, 89.07%) STEMI, (88.81%, 88.05%, 91.23%, 91.38%) NSTEMI. The AUC values in RF were (98.96%, 98.15%, 98.81%), ET (99.54%, 99.02%, 99.00%), GBM (98.92%, 99.33%, 99.41%), and SVE (99.61%, 99.49%, 99.42%) for complete dataset, STEMI, and NSTEMI, respectively. Consequently, the accuracy and AUC in SVE outperformed other ML models.
CONCLUSIONS: The performance of our SVE was significantly higher than other machine learning models (RF, ET, GBM) and its major prognostic factors were different. This paper will lead to the development of early risk prediction and diagnosis tool of MACE in ACS patients.

Entities:  

Year:  2021        PMID: 34115750     DOI: 10.1371/journal.pone.0249338

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  6 in total

Review 1.  Predicting Major Adverse Cardiovascular Events in Acute Coronary Syndrome: A Scoping Review of Machine Learning Approaches.

Authors:  Sara Chopannejad; Farahnaz Sadoughi; Rafat Bagherzadeh; Sakineh Shekarchi
Journal:  Appl Clin Inform       Date:  2022-05-26       Impact factor: 2.762

2.  Machine Learning Analyzed Weather Conditions as an Effective Means in the Predicting of Acute Coronary Syndrome Prevalence.

Authors:  Aleksandra Wlodarczyk; Patrycja Molek; Bogdan Bochenek; Agnieszka Wypych; Jadwiga Nessler; Jaroslaw Zalewski
Journal:  Front Cardiovasc Med       Date:  2022-04-08

3.  Inspection of Underwater Hull Surface Condition Using the Soft Voting Ensemble of the Transfer-Learned Models.

Authors:  Byung Chul Kim; Hoe Chang Kim; Sungho Han; Dong Kyou Park
Journal:  Sensors (Basel)       Date:  2022-06-10       Impact factor: 3.847

4.  A clustering-based sampling method for miRNA-disease association prediction.

Authors:  Zheng Wei; Dengju Yao; Xiaojuan Zhan; Shuli Zhang
Journal:  Front Genet       Date:  2022-09-13       Impact factor: 4.772

5.  A Machine Learning Model for Predicting Unscheduled 72 h Return Visits to the Emergency Department by Patients with Abdominal Pain.

Authors:  Chun-Chuan Hsu; Cheng-C J Chu; Ching-Heng Lin; Chien-Hsiung Huang; Chip-Jin Ng; Guan-Yu Lin; Meng-Jiun Chiou; Hsiang-Yun Lo; Shou-Yen Chen
Journal:  Diagnostics (Basel)       Date:  2021-12-30

Review 6.  A Powerful Paradigm for Cardiovascular Risk Stratification Using Multiclass, Multi-Label, and Ensemble-Based Machine Learning Paradigms: A Narrative Review.

Authors:  Jasjit S Suri; Mrinalini Bhagawati; Sudip Paul; Athanasios D Protogerou; Petros P Sfikakis; George D Kitas; Narendra N Khanna; Zoltan Ruzsa; Aditya M Sharma; Sanjay Saxena; Gavino Faa; John R Laird; Amer M Johri; Manudeep K Kalra; Kosmas I Paraskevas; Luca Saba
Journal:  Diagnostics (Basel)       Date:  2022-03-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.